May 31, 2024 10:29 ET
Gattaca Genomics Launches Landmark Study to Revolutionize Embryo Selection in IVF
Gattaca Genomics, a pioneer in genetic diagnostics and reproductive technologies, is proud to announce Institutional Review Board (IRB) approval for its multi-center study, "Embryo Assessment Utilizing Timelapse Imaging in Conjunction With Preimplantation Genetic Testing for Aneuploidy With Next Generation Sequencing." This groundbreaking study will examine the relationship between embryo development and aneuploidy, a condition where embryos have an abnormal number of chromosomes.
The study is currently recruiting IVF centers interested in participating, by collaborating with clinics worldwide, Gattaca Genomics aims to collect a large and diverse dataset that will provide valuable insights into the complex relationship between embryo development and aneuploidy. Read More
March 26, 2024 08:22 ET
Gattaca Genomics Partners with Ibanera to Revolutionize Digital Banking for Family Planning Innovation
Gattaca Genomics, a pioneer in genetic diagnostics and reproductive technologies, proudly announces its strategic partnership with Ibanera, a leading provider of innovative fintech and banking services. This dynamic collaboration marks a significant advancement, facilitating financial services and payments for Gattaca's cutting-edge genetic testing services through Ibanera's state-of-the-art financial solutions.
Medical institutions worldwide can now leverage Gattaca Genomics' unparalleled expertise in genetic research and diagnostics, complemented by the embedded payment and financial services provided by Ibanera's advanced technologies. Read More
March 6, 2024 08:22 ET
Gattaca Genomics Appoints Dr. Tyl Taylor as New Director of Genetics Services
Gattaca Genomics, a leading name in genetic services, appoints Dr. Tyl Taylor as its new Director of Genetics Services. Dr. Taylor brings a wealth of experience and expertise in the field, making him a valuable addition to the Gattaca team.
In his role as the Director of Genetics Services at Gattaca, Dr. Taylor is poised to lead the team towards new heights in genetic research and reproductive technologies. His vision aligns with Gattaca's commitment to excellence and innovation, ensuring that the company continues to be at the forefront of cutting-edge genetic services.
With a rich history of contributions to the field of genetics, Dr. Taylor has served as the Director of Laboratory Services at Reproductive Endocrinology Associates of Charlotte (REACH), overseeing all aspects of in vitro fertilization (IVF) and managing a team of 10 embryologists/andrologists. Read More
Feb 6, 2024 08:22 ET
Gattaca Genomics Leads the Way in Revolutionizing Fertility with Artificial Intelligence for Full Genome Analysis, Including Preimplantation Genetic Testing and Genetic Counseling
Gattaca Genomics, a pioneering force in the field of fertility, is proud to announce its ground-breaking approach to genetic preimplantation testing, whole genome sequencing and counseling. By integrating advanced artificial intelligence (AI) technologies the company aspires to enhance the success rates of fertility procedures.
Utilizing sophisticated hyperparameter turning and deep learning, Gattaca Genomics develops precise genetic analysis, identifying anomalies and patterns with unparalleled accuracy. By comparing vast datasets, AI enhances the identification of genetic abnormalities such as aneuploidies and chromosomal structural abnormalities, contributing to improved precision and reliability in embryo screening.
Harnessing the power of large language models (LLM), Gattaca Genomics transforms the landscape of genetic counseling in assisted reproductive processes. Through a comprehensive analysis of genetic data from embryos, including preimplantation genetic testing (PGT) and full genome analysis, Gattaca's AI-driven neural network will discern crucial efficiencies and deficiencies, ensuring more successful outcomes for patients. Read More
Get Started
Follow us on Twitter, LinkedIn, Instagram and Facebook for the latest news and updates.
